The idea that peptides are just steroids under another name is a category error, and it matters for anyone shopping among prescription providers. The two are governed by different laws, dispensed through different channels, and priced by different forces.
Why the legal category is not the same
Anabolic steroids are Schedule III controlled substances in the United States. That designation carries specific prescribing, storage, and recordkeeping requirements. The peptides named in the source article do not fall into that scheme. They are regulated as drugs or investigational agents, not as controlled substances, so the rules that shape their availability come from a different part of the framework.
This is not a small distinction. It determines which pharmacies can handle a product, whether a compounder can prepare it, and what a prescriber must document. Treating peptides as if they were steroids leads people toward the wrong questions and, sometimes, the wrong sellers.
Where each named peptide stands
Semaglutide and tirzepatide are the GLP-1 medicines most people recognize. Both are FDA approved as branded products for defined uses. Compounded versions have circulated during shortage-driven periods, and the legality of that compounding hinges on shortage status and the specific pharmacy category involved. Because these two are approved drugs, the cleanest path is a prescription filled at a licensed pharmacy that dispenses the approved product.
Tesamorelin is also an FDA approved product with a specific labeled indication. Availability through a licensed pharmacy depends on a valid prescription tied to that clinical picture.
Semax is different. It is not an FDA approved drug in the United States, and it is best understood as investigational here. Thymosin-alpha-1 sits outside the approved-drug category in the United States as well. When a compound is investigational and unapproved, legitimate access is narrow, and any site offering it freely as a consumer product deserves skepticism.
What actually drives cost
For approved products, price reflects manufacturer pricing, insurance coverage, and whether a compounded alternative is legally permitted at a given moment. For compounded preparations, the pharmacy's category matters. A 503A pharmacy compounds for individual patients against specific prescriptions. A 503B outsourcing facility operates under stricter manufacturing oversight and can produce larger batches. Those structures carry different cost and quality profiles, and a provider should be able to tell you which one is filling your prescription.
Be wary of pricing that looks far below the market for an approved drug. Unusually cheap offers often signal a research-use-only vendor rather than a licensed pharmacy, and those are not a legal purchase channel for personal use.
How to vet a provider
The questions that separate a legitimate operation from a gray-market one are practical and worth asking directly.
- Does a licensed clinician evaluate you before anything is prescribed, and are they licensed in your state?
- Which licensed pharmacy fills the order, and is it a 503A or 503B facility?
- Is the specific compound FDA approved, or is it investigational or unapproved for the intended use?
- Can the provider explain the legal basis for any compounded version they offer?
A provider that answers these plainly is easier to trust than one that markets peptides as interchangeable with steroids or that sidesteps the pharmacy question entirely.
The bottom line
Peptides and steroids are not the same thing legally, and the differences among individual peptides matter just as much. Approved products like the GLP-1 medicines and tesamorelin have a defined pharmacy path. Others, including semax and thymosin-alpha-1, are investigational or unapproved in the United States, which narrows legitimate access considerably.
This is general information, not medical advice. Decisions about any of these compounds belong with a licensed clinician who knows your history and can prescribe through a pharmacy you can verify.